Inogen | INGN - Loan Capital


Inogen reported $0 in Loan Capital for its fiscal quarter ending in June of 2022.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Accuray USD 124.78M 2.54M Dec/2025
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 215.35M 2.46M Mar/2026
AtriCure USD 61M 865K Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Boston Scientific USD 11.01B 19M Dec/2025
Chart Industries USD 3.79B 221.7M Mar/2026
Cooper Companies USD 1.86B 17.7M Mar/2026
Dexcom USD 1.3B 54.4M Mar/2026
Edwards Lifesciences USD 600M 1.7M Mar/2026
Globus Medical USD 436K 9K Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 929.5M 1.3M Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Orthofix International USD 221.33M 46.88M Mar/2026
Philips EUR 6.89B 43M Mar/2026
ResMed USD 404.17M 245K Mar/2026
Steris USD 1.81B 85.6M Mar/2026
Stryker USD 14.22B 635M Mar/2026
Tandem Diabetes Care USD 601.77M 291.73M Mar/2026
Teleflex USD 2.51B 27.18M Mar/2026
X T L Biopharmaceuticals USD 0 0 Dec/2024
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026